AANEM News Express

AANEM News Express

Science News: Schwann Cell Transcript Biomarkers For Hereditary Neuropathy Skin Biopsies

10/22/2019
 
Submitted by Clark Pinyan, MD
Edited by Nandita Keole, MD


Schwann Cell Transcript Biomarkers For Hereditary Neuropathy Skin Biopsies. Svaren J et al. Ann Neurol 2019;85:887-898

Authors used quantitative PCR measurements to determine levels of PMP22 mRNA in skin biopsies of patients with CMT1A compared with controls. Though PMP22 mRNA expression is known to be increased in CMT1A affected Schwann cells, its level in biopsies is variable from patient to patient and doesn’t correlate well with clinical disease, largely due to variability in number of Schwann cells present. Authors attempted to normalize PMP22 mRNA expression vs. Schwann cell specific genes which are not altered by CMT1A status. This showed reproducible elevations in PMP22 compared to controls.

Comments: Skin biopsy is a commonly used practice for autonomic or small fiber neuropathy, and special staining techniques or analysis may become relevant for specific disorders. As treatments emerge for CMT, skin biopsy may prove a useful marker for treatment response or disease progression. 


View Related News Stories:

  EducationScience News


Recent AANEM News

Remembering George Kraft, MD, MS

The American Clinical Neurophysiology Society to Hold Another Townhall Meeting of Clinical Neurophysiology, Epilepsy, and Neuromuscular Fellowship Program Directors

Science News: Amyotrophic Lateral Sclerosis and Noninvasive Positive Pressure Ventilatory Support: "Nasal Noninvasive Ventilation" or "Noninvasive Ventilatory Support"?

CMS Finalizes Updates to Physician Fee Schedule

Advocacy in Action: State Liaison Leads the Way for Patient Advocacy in Washington and Beyond





Advertisement

ABEM

Advertisement

Donate

Advertisement